You should submit comments and suggestions regarding this draft document within 120 days of publication in the Federal Register of the notice announcing the availability of the draft guidance. Submit written comments to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Submit electronic comments to http://www.regulations.gov . Identify all comments with the docket number listed in the notice of availability that publishes in the Federal Register.
For questions regarding this document contact (CDRH) Diane Garcia at 301-796-6559 or email@example.com , or (CBER) the Office of Communication, Outreach, and Development at 800-835-4709 or 301-827-1800.
U.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health Center for Biologics Evaluation and Research
Food and Drug Administration
Center for Devices and Radiological Health
Center for Biologics Evaluation and Research
- Program Operations Staff/Office of Device Evaluation - 301-796-5640
- Product Classification Database 
- Office of Regulatory Affairs (ORA) Product Code Builder 
- Device Advice – Device Regulation and Guidance 
- Device Classification 
- Medical Device Listing 
- Convenience Kits Guidance 
- Medical Device Reporting (MDR) 
- Industry Procedures for Section 513(g) Requests for Information 
- Evaluation of Automatic Class III Designation, Guidance for Industry and CDRH Staff (De Novo) 
1 An unclassified device is a pre-amendments device for which a classification regulation has not been promulgated. Unclassified devices require submission of a 510(k) premarket notification to CDRH. A not-classified device is a post-amendments device that the Agency has not yet reviewed or for which the Agency has not made a final decision. A pre-amendments device is a device that was on the market prior to the enactment of the Medical Device Amendments to the FD&C Act on May 28, 1976.
7 See 21 CFR Part 807.
11 See 21 CFR Part 807.
12 Refer to the Draft Guidance for Industry and FDA Staff: FDA and Industry Procedures for Section 513(g) Requests for Information under the Federal Food, Drug, and Cosmetic Act  on FDA’s website, and the Draft Guidance for Industry and FDA Staff: User Fees for 513(g) Requests for Classification Information .